Idenix Pharmaceuticals: Hepatitis B (HBV), Hepatitis C (HCV), and HIV Drug Development ... Idenix Pharmaceuticals to present at the Bank of America 2008 Specialty Pharmaceuticals ...
Idenix Pharmaceuticals: Hepatitis C (HCV) Drug Development ... drug development & discovery. Since the discovery of the hepatitis C virus in 1989, many antiviral targets have been ...
Read news articles related to Idenix Pharmaceuticals to Present at the Seventh Annual Needham and Company, LLC Biotechnology and Medical Technology Conference on Boston.com
Find financial news, press releases and podcasts for Idenix Pharmaceuticals, Inc. (IDIX) on Boston.com
Idenix Pharmaceuticals: Job Postings ... Careers at Idenix: At Idenix, our corporate values - Innovation, Teamwork, Respect, Quality and Ownership - reflect a unique and dynamic ...
Idenix Pharmaceuticals: Job Postings ... Job Details. Idenix Pharmaceuticals, Inc., headquartered in Cambridge, MA, is a biopharmaceutical company engaged in the discovery ...
Start research for Idenix Pharmaceuticals Inc IDIX.O stock data, including stock quotes, stock trading and stock prices at Reuters.com. Read Idenix Pharmaceuticals Inc IDIX ...
Read the Idenix Pharmaceuticals Inc IDIX.O company profile at Reuters.com. ... Idenix Pharmaceuticals, Inc. is a biopharmaceutical company engaged in the discovery and ...
Idenix Pharmaceuticals has cleared successes from its development board and is pushing forward with later stages of a phase II HIV medication.
IDENIX PHARMACEUTICALS INC: IDIX (Nasdaq National Mkt)
Challenge. Through the startup phase, Idenix focused on its scientific expertise and processes. Once going public, however, it was time for Idenix to focus on marketing and ...
CONTACT US: NEW YORK Lisa Scoville 617.875.6297 tel lisa@bluerae.com BOSTON Kris Knight 857.383.8553 tel kris@bluerae.com Tracy Mazzuca 508.238.8518 tel tracy@bluerae.com ABOUT ...
See the company profile for IDENIX PHARMACEUT (IDIX) including business summary, industry/sector information, number of employees, business summary, corporate governance, key ...
Idenix Pharmaceuticals, Inc. Receives The French Lifesciences Award at BIO 2003
CAMBRIDGE, Mass., Feb. 6 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX) announced today that Idenix management will present a corporate overview at the ...
Idenix Pharmaceuticals, Inc. Announces Data Presentations at the 43rd Annual Meeting of the European Association for the Study of the Liver
Idenix Pharmaceuticals, Inc. is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases.
FOR IMMEDIATE RELEASE Idenix Pharmaceuticals' Contact: Teri Dahlman (617) 995-9905 IDENIX PHARMACEUTICALS PROVIDES UPDATE ON HEPATITIS C PIPELINE AT JP MORGAN HEALTHCARE CONFERENCE ...
Idenix Pharmaceuticals Advances HCV Discovery Program to Clinic: several new HCV drugs in development Posted : Tue, 29 Jul 2008 11:05:27 GMT
Research Idenix Pharmaceuticals with InvestorGuide.com stock research tool. IDIX profile, EDGAR SEC filings, executives, corporate address, description, competitors, institutional ...
MarketWatch, a leading publisher of business and financial news, offers users up-to-the minute news, investment tools, and subscription products. ...
Get detailed information on Idenix Pharmaceuticals, Inc. (IDIX) including quotes, news, returns, research and ratings, as well as charts, valuations, financial statements ... What ...
Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious ...
Membership Directory Idenix Pharmaceuticals, Inc. Category: Drug Development Phone: 617-995-9800 Fax: 617-995-9801 Website: http://www.idenix.com. Idenix Pharmaceuticals Inc. is a ...
Find relationships for Idenix Pharmaceuticals Inc. (IDIX) Board of Directors members. Learn about other board affiliations & connections to other executives.
NEW! The Deal Journal Blog: Updated throughout the market day with exclusive commentary, news flashes, profiles, data and more, The Deal Journal provides you
Jul. 31 : Idenix Pharmaceuticals to Present at the Bank of America 2008 Specialty Pharmaceuticals Conference: Jul. 29 : Idenix Pharmaceuticals Advances HCV Discovery Program to ...
Idenix Pharmaceuticals to Present at the BMO Capital Markets 2008 Focus on Healthcare Conference. - CAMBRIDGE, Mass., July 24 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc ...
|
|